Skip to main content

Table 2 Antioxidant defence system and oxidative stress markers in liver tissues of control and carcinogenic male albino rats treated with either pomegranate juice (PJ) or punicalagin (PCG)

From: Pomegranate juice and punicalagin-mediated chemoprevention of hepatocellular carcinogenesis via regulating miR-21 and NF-κB-p65 in a rat model

Group

Non-carcinogenic groups

Carcinogenic groups

Control

PJ

(10 mL/ kg b.w)

PCG

(18.5 mg/ kg b.w)

HCC

(50 mg DENA/ kg b.w)

HCC

(50 mg DENA/kg b.w)

 + 

PJ(10 mL/ kg b.w)

HCC

(50 mg DENA/ kg b.w)

 + 

PCG (18.5 mg/ kg b.w)

MDA level

(μM/mg protein)

80.44 ± 3.82

74.54 ± 3.36

92.19 ± 4.06

117.76 ± 0.06**

82.25 ± 5.80##

74.65 ± 5.68###

NO level

(μmol/ L)

18.74 ± 1.14

19.34 ± 0.81

19.86 ± 0.39

23.65 ± 0.89***

19.19 ± 0.31##

17.34 ± 0.30###

GST activity

(U/ mg protein)

8.55 ± 0.51

10.83 ± 0.57

10.05 ± 1.08

12.39 ± 0.92*

8.25 ± 0.52#

8.64 ± 1.15#

SOD activity

(U/ mg protein)

79.79 ± 2.78

87.16 ± 4.62

75.23 ± 4.59

39.95 ± 2.01***

68.26 ± 2.77###

65.21 ± 1.88*###

CAT activity

(U/ mg protein)

91.04 ± 3.58

79.39 ± 4.93

75.64 ± 1.52

69.19 ± 2.98*

94.32 ± 4.61##

75.24 ± 5.94

  1. Data are presented as means and their standard error of means (n = 5 in each group). CAT catalase, GST glutathione S-transferase, HCC hepatocellular carcinogenesis control group, MDA malondialdehyde, NO nitric oxide, SOD superoxide dismutase
  2. *, ** and ***: P < 0.05, P < 0.01 and P < 0.001 (compared to control group)
  3. #, ##and ###: P < 0.05, P < 0.01 and P < 0.001 (compared to HCC control group)